199 related articles for article (PubMed ID: 31294884)
21. The multidrug transporter Pdr5 on the 25th anniversary of its discovery: an important model for the study of asymmetric ABC transporters.
Golin J; Ambudkar SV
Biochem J; 2015 May; 467(3):353-63. PubMed ID: 25886173
[TBL] [Abstract][Full Text] [Related]
22. Mutations of charged amino acids at the cytoplasmic end of transmembrane helix 2 affect transport activity of the budding yeast multidrug resistance protein Pdr5p.
Dou W; Zhu J; Wang T; Wang W; Li H; Chen X; Guan W
FEMS Yeast Res; 2016 Jun; 16(4):. PubMed ID: 27189366
[TBL] [Abstract][Full Text] [Related]
23. Subcellular trafficking of the yeast plasma membrane ABC transporter, Pdr5, is impaired by a mutation in the N-terminal nucleotide-binding fold.
de Thozée CP; Cronin S; Goj A; Golin J; Ghislain M
Mol Microbiol; 2007 Feb; 63(3):811-25. PubMed ID: 17302805
[TBL] [Abstract][Full Text] [Related]
24. Mutations adjacent to the end of transmembrane helices 6 and 7 independently affect drug efflux capacity of yeast ABC transporter Pdr5p.
Chen Z; Li J; Wang W; Guo X; Li Y; Mao X; Chen X; Guan W
Biochim Biophys Acta; 2014 Mar; 1838(3):932-9. PubMed ID: 24333836
[TBL] [Abstract][Full Text] [Related]
25. The multidrug transporter Pdr5: a molecular diode?
Gupta RP; Kueppers P; Schmitt L; Ernst R
Biol Chem; 2011 Jan; 392(1-2):53-60. PubMed ID: 21194365
[TBL] [Abstract][Full Text] [Related]
26. The deviant ATP-binding site of the multidrug efflux pump Pdr5 plays an active role in the transport cycle.
Furman C; Mehla J; Ananthaswamy N; Arya N; Kulesh B; Kovach I; Ambudkar SV; Golin J
J Biol Chem; 2013 Oct; 288(42):30420-30431. PubMed ID: 24019526
[TBL] [Abstract][Full Text] [Related]
27. Prenyl-flavonoids as potent inhibitors of the Pdr5p multidrug ABC transporter from Saccharomyces cerevisiae.
Conseil G; Decottignies A; Jault JM; Comte G; Barron D; Goffeau A; Di Pietro A
Biochemistry; 2000 Jun; 39(23):6910-7. PubMed ID: 10841772
[TBL] [Abstract][Full Text] [Related]
28. The ATP-binding cassette multidrug transporter Snq2 of Saccharomyces cerevisiae: a novel target for the transcription factors Pdr1 and Pdr3.
Mahé Y; Parle-McDermott A; Nourani A; Delahodde A; Lamprecht A; Kuchler K
Mol Microbiol; 1996 Apr; 20(1):109-17. PubMed ID: 8861209
[TBL] [Abstract][Full Text] [Related]
29. Endocytosis and vacuolar degradation of the plasma membrane-localized Pdr5 ATP-binding cassette multidrug transporter in Saccharomyces cerevisiae.
Egner R; Mahé Y; Pandjaitan R; Kuchler K
Mol Cell Biol; 1995 Nov; 15(11):5879-87. PubMed ID: 7565740
[TBL] [Abstract][Full Text] [Related]
30. A novel screening for inhibitors of a pleiotropic drug resistant pump, Pdr5, in Saccharomyces cerevisiae.
Hiraga K; Wanigasekera A; Sugi H; Hamanaka N; Oda K
Biosci Biotechnol Biochem; 2001 Jul; 65(7):1589-95. PubMed ID: 11515543
[TBL] [Abstract][Full Text] [Related]
31. The signaling interface of the yeast multidrug transporter Pdr5 adopts a cis conformation, and there are functional overlap and equivalence of the deviant and canonical Q-loop residues.
Ananthaswamy N; Rutledge R; Sauna ZE; Ambudkar SV; Dine E; Nelson E; Xia D; Golin J
Biochemistry; 2010 Jun; 49(21):4440-9. PubMed ID: 20426485
[TBL] [Abstract][Full Text] [Related]
32. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: expression of a yeast multidrug transporter in baculovirus expression system.
Krishnamurthy S; Chatterjee U; Gupta V; Prasad R; Das P; Snehlata P; Hasnain SE; Prasad R
Yeast; 1998 Apr; 14(6):535-50. PubMed ID: 9605504
[TBL] [Abstract][Full Text] [Related]
33. Nonsynonymous Mutations in Linker-2 of the Pdr5 Multidrug Transporter Identify a New RNA Stability Element.
Rahman H; Rudrow A; Carneglia J; Joly SSP; Nicotera D; Naldrett M; Choy J; Ambudkar SV; Golin J
G3 (Bethesda); 2020 Jan; 10(1):357-369. PubMed ID: 31757931
[TBL] [Abstract][Full Text] [Related]
34. Site-directed mutagenesis of Asp853 in Pdr3p transcriptional activator from Saccharomyces cerevisiae.
Dzugasova V; Borecka S; Batova M; Pilisiova R; Hervayova N; Subik J
Yeast; 2010 May; 27(5):277-84. PubMed ID: 20146400
[TBL] [Abstract][Full Text] [Related]
35. Regulation of yeast nutrient permease endocytosis by ATP-binding cassette transporters and a seven-transmembrane protein, RSB1.
Johnson SS; Hanson PK; Manoharlal R; Brice SE; Cowart LA; Moye-Rowley WS
J Biol Chem; 2010 Nov; 285(46):35792-802. PubMed ID: 20826817
[TBL] [Abstract][Full Text] [Related]
36. Functional characterization of the Saccharomyces cerevisiae ABC-transporter Yor1p overexpressed in plasma membranes.
Grigoras I; Lazard M; Plateau P; Blanquet S
Biochim Biophys Acta; 2008 Jan; 1778(1):68-78. PubMed ID: 17950691
[TBL] [Abstract][Full Text] [Related]
37. RPD3 and ROM2 are required for multidrug resistance in Saccharomyces cerevisiae.
Borecka-Melkusova S; Kozovska Z; Hikkel I; Dzugasova V; Subik J
FEMS Yeast Res; 2008 May; 8(3):414-24. PubMed ID: 18205807
[TBL] [Abstract][Full Text] [Related]
38. Domain interactions in the yeast ATP binding cassette transporter Ycf1p: intragenic suppressor analysis of mutations in the nucleotide binding domains.
Falcón-Pérez JM; Martínez-Burgos M; Molano J; Mazón MJ; Eraso P
J Bacteriol; 2001 Aug; 183(16):4761-70. PubMed ID: 11466279
[TBL] [Abstract][Full Text] [Related]
39. A New Twist in ABC Transporter Mediated Multidrug Resistance - Pdr5 is a Drug/proton Co-transporter.
Wagner M; Blum D; Raschka SL; Nentwig LM; Gertzen CGW; Chen M; Gatsogiannis C; Harris A; Smits SHJ; Wagner R; Schmitt L
J Mol Biol; 2022 Jul; 434(14):167669. PubMed ID: 35671830
[TBL] [Abstract][Full Text] [Related]
40. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p.
Decottignies A; Grant AM; Nichols JW; de Wet H; McIntosh DB; Goffeau A
J Biol Chem; 1998 May; 273(20):12612-22. PubMed ID: 9575223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
